Elacestrant in Combination with Everolimus for Estrogen Receptor-Positive, HER2-Negative Previously Treated Advanced Breast Cancer: Results from ELEVATE - Hope S. Rugo; Sara M. Tolaney; Nancy Chan; Giuliano Borges; Rinat Yerushalmi; Marina N. Sharifi; Wassim McHayleh; Thaddeus Beck; Neelima Vidula; Erika Hamilton; Kristine J. Rinn; Joyce O'Shaughnessy; et al. (Clinical Cancer Research, 2026)